TIGIT Antibody / VSTM3 / VSIG9
TIGIT is a checkpoint inhibitor which binds with high affinity to the poliovirus receptor (PVR), causing increased IL10 secretion, decreased IL12B secretion. TIGIT binding to PVR also causes the suppression of T cell activation by promoting the generation of mature immuno-regulatory dendritic cells. It is expressed at low levels on natural killer (NK) cells, as well as peripheral memory and regulatory CD4+ T cells. At the protein level, it is upregulated following the activation of these cells. Functionally, TIGIT is similar to CTLA4. The ligands for TIGIT include CD155 (signal abrogation) and CD226 (signal stimulation) . It has been demonstrated to be upregulated on T cells in many cancers and is a immuno-oncology target for therapy.
Product Specifications
CAS Number
9007-83-4
Specifications
UniProt
Q495A1
Host
Mouse
Reactivity
Human
Immunogen
A recombinant human TIGIT protein fragment within amino acids 194-244 was used as the immunogen for the TIGIT antibody.
Clonality
Monoclonal
Isotype
IgG2b κ
Clone
TIGIT/3106
Applications
IHC-P
Purity
Protein G affinity chromatography
Format
Purified
Buffer
Prediluted in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide; *For IHC use only*
Reconstitution
Store the TIGIT antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Limitations
This TIGIT antibody is available for research use only.
Storage Conditions
Store the TIGIT antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide) .
Formulation
Prediluted in 1X PBS, 0.1 mg/mL BSA (US sourced), 0.05% sodium azide; *For IHC use only*
Image Legend
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items